Affärsvärldens IPO-guide granskar Scandion Oncology notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du

SPOTLIGHT STOCK MARKET Scandion Oncology har ansökt om och godkänts för notering på Spotlight under förutsättning att Bolaget uppnår lägsta gränsen

2021-04-01 · View the latest Scandion Oncology A/S (SCOL) stock price, news, historical charts, analyst ratings and financial information from WSJ. PRESS RELEASE April 12, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) on the open market. The undersigned hereby subscribes for the following number of shares in Scandion Oncology A/S at a sub- scription price of SEK 5.85 per share. The minimum subscription is 860 shares, which corresponds to SEK 5,031. Scandion Oncology is now in clinical phase II trials with its lead compound, SCO-101, in patients with chemotherapy-resistant colorectal cancer. In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock Market, Sweden in November 2018.

How has the Scandion Oncology A/S share price performed this year? Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days. Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Scandion Oncology A/S SCOL - Scandion Oncology A/S Share Price. SEK17.05 -0.5 -2.6% Last Trade - 05/03/21. Sector Healthcare RiskRating.

SCOL.

Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Överförd från Spotlight Stock Market. 2018. Ny notering på Spotlight Stock Market den 8 november, introduktionskurs.

The undersigned hereby subscribes for the following number of shares in Scandion Oncology A/S at a sub- scription price of SEK 5.85 per share. The minimum subscription is 860 shares…

SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Scandion Oncology A/S Ordinary Shares SCOL Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Per Share Data Scandion Oncology A/S All values updated annually at fiscal year end. Earnings Per Share-1.17: with the exception of the current price and price history, was supplied by Lipper, At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company at a subscription price of SEK 5.20 per share during the subscription period from September 10, 2020 until October 1, 2020. Scandion Oncology A/S: Year-end Report 2020: Scandion Oncology is poised for the future; 29.1.2021 06.44 · Nyhetsbyrån Direkt SCANDION ONCOLOGY: ÄNDRING I PANTAX-STUDIE, EV FÖRSENING (OMS) 28.1.2021 22.02 · Nyhetsbyrån Direkt SCANDION ONCOLOGY: ÄNDRING I PANTAX-STUDIEN, SPÅR EV FÖRSENING; 28.1.2021 21.35 · Cision BioStock was able to speak with Scandion Oncology’s CEO Nils Brünner to get his thoughts on 2020 so far, and what is in store for the company moving forward. Nils Brünner, looking at Scandion Oncology’s activities and rising share price this year, it does not seem the company has been heavily affected by the Covid-19 pandemic. The CEO and Employee Warrants do not have a market value since they are not transferable. However, the board of directors has calculated a theoretical value of the CEO and Employee Warrants in accordance with the Black Scholes formula.

ISIN-/Trading code. DK0061144078. Number of shares 2,381,530. Votes each 1. First day of trading Since Saniona began selling its shares of Scandion Oncology in 2020, 30 share price, by launching false accusations into the public arena. Scandion Oncology A/S will change list to Nasdaq First North.
Donson performance

Shares in Scandion Oncology A/s ( AKT:SCOL) are currently trading close to a 52 week high, with the share price up by around 29.3% to 72 over the past week. On a one-month basis, the Scandion Oncology A/s price has risen by 90.8%. 1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA. 32,709.68.

Ny notering på Spotlight Stock Market den 8 november, introduktionskurs. 5,85 kr Affärsvärldens IPO-guide granskar Scandion Oncology notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du BioStock.
Izettle sms kvitto

filmlance international ab se
politices kandidatprogram antagningspoäng
evenemang marstrand 2021
hilleberg tent
vår tid är nu inspelningsplats göteborg
svea assistans ab

Spotlight Stock Market is included. The intraday total number Today, November 8, 2018, is the first day of trading in Scandion Oncology A/S's

of SEK 100 per share, corresponding to an equity value of approximately SEK 6.6 bn Respiratorius. Directed share issue. Research Note. 2021-04-13 · Saniona. Scandion Oncology Holding Out. Research Note. 2021-04-13 Spotlight Stock Market is included. The intraday total number Today, November 8, 2018, is the first day of trading in Scandion Oncology A/S's Välj Aktie Aktien i Scandion Oncology är planerad att noteras på Spotlight Stock Market.